A Phase 1, Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Doses of PF-06273340 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 May 2014
At a glance
- Drugs PF 6273340 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Mar 2014 Trials status changed to completed as reported by ClinicalTrials.gov.
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 11 Sep 2013 New trial record